Pembrolizumab (pembro) for relapsed malignant pleural mesothelioma (MPM): Outcomes in real-life setting in Australia (AUS) and Switzerland (CH)

Titel:: Pembrolizumab (pembro) for relapsed malignant pleural mesothelioma (MPM): Outcomes in real-life setting in Australia (AUS) and Switzerland (CH)
Dokumenttyp:: Meeting Abstract
Autor(en):: Mauti, L; Rivalland, G; Klingbiel, D; Kao, S; Schmid, S; Nowak, A; Gautschi, O; Hughes, B; Bartnick, T; Pavlakis, N; Bouchaab, H; OByrne, K; Rothschild, S; Russell, P; Prince, SS; Thapa, B; Pless, M; von Moos, R; Metaxas, Y; John, T
Zeitschriftentitel:: Ann Oncol
Jahr:: 2017
Band / Volume:: 28 11
Seitenangaben Beitrag:: 8-8
Sprache:: eng
Print-ISSN:: 0923-7534
TUM Einrichtung:: Urologische Klinik und Poliklinik
BibTeX

Vorkommen: